Active Ingredient(S)
Bismuth subsalicylate 262 mg (total salicylate 102 mg per tablet)
The following Structured Product Label (SPL) was submitted to the FDA by Good Sense (geiss, Destin & Dunn, Inc.) for the product Goodsense Regular Strength Stomach Relief 122 (NDC 50804-152). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, use(s), warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Bismuth subsalicylate 262 mg (total salicylate 102 mg per tablet)
Upset stomach reliever and anti-diarrheal
relieves:
Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
____________________________________________________________________________________________________________
Allergy alert: Contains salicylate. Do not take if you are
if you have
taking any drug for
a temporary, but harmless darkening of the stool and/or tongue may occur.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center immediately.
calcium carbonate, D&C red 27 aluminum lake, flavor, Magnesium stearate, mannitol, pregelatinized starch, saccharin sodium.
OODSENSE ®
Regular Strength
NDC 50804-152-49
Stomach Relief Tablets
Bismuth Subsalicylate 262 mg
Antidiarrheal/Upset Stomach Reliever
Soothing Relief For
5 Symptoms
Actual Size
* Compare to active ingredient of Pepto-Bismol® Chewable Tablets
30 Chewable Tablets
* Please review the disclaimer below.